178 related articles for article (PubMed ID: 7583574)
1. Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques. Effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits.
Shiomi M; Ito T; Tsukada T; Yata T; Watanabe Y; Tsujita Y; Fukami M; Fukushige J; Hosokawa T; Tamura A
Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1938-44. PubMed ID: 7583574
[TBL] [Abstract][Full Text] [Related]
2. Pravastatin decreases serum lipids and vascular cholesterol deposition in Watanabe heritable hyperlipidemic (WHHL) rabbits.
Khachadurian AK; Shimamura T; Rozovski SJ; Ananthakrishnan R; Armenian B; Coly E; alHinai A; Martucci C; Schneider SH; Amorosa LF
Jpn Heart J; 1991 Sep; 32(5):675-85. PubMed ID: 1774829
[TBL] [Abstract][Full Text] [Related]
3. Effect of fluvastatin sodium on the smooth muscle cells in atherosclerotic plaques. In vivo study using low-density lipoprotein receptor deficient Watanabe heritable hyperlipidemic (WHHL) rabbits.
Shiomi M; Ito T; Tsukada T; Shiraishi M; Yata T
Arzneimittelforschung; 1998 Jun; 48(6):680-5. PubMed ID: 9689427
[TBL] [Abstract][Full Text] [Related]
4. Effect of cerivastatin sodium, a new inhibitor of HMG-CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbits.
Shiomi M; Ito T
Br J Pharmacol; 1999 Feb; 126(4):961-8. PubMed ID: 10193776
[TBL] [Abstract][Full Text] [Related]
5. Fibromuscular cap composition is important for the stability of established atherosclerotic plaques in mature WHHL rabbits treated with statins.
Shiomi M; Ito T; Hirouchi Y; Enomoto M
Atherosclerosis; 2001 Jul; 157(1):75-84. PubMed ID: 11427206
[TBL] [Abstract][Full Text] [Related]
6. Cell compositions of coronary and aortic atherosclerotic lesions in WHHL rabbits differ. An immunohistochemical study.
Shiomi M; Ito T; Tsukada T; Yata T; Ueda M
Arterioscler Thromb; 1994 Jun; 14(6):931-7. PubMed ID: 8199184
[TBL] [Abstract][Full Text] [Related]
7. The effect of cholesterol reduction on the endothelial function and progression of atherosclerosis in WHHL rabbits.
Kroon AA; Stalenhoef AF; Buikema H; Demacker PN; de Wilde PC; Leijten PA; van Gilst WH
Atherosclerosis; 1993 Nov; 103(2):221-30. PubMed ID: 8292097
[TBL] [Abstract][Full Text] [Related]
8. Probucol treatment attenuates the aortic atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
Oshima R; Ikeda T; Watanabe K; Itakura H; Sugiyama N
Atherosclerosis; 1998 Mar; 137(1):13-22. PubMed ID: 9568732
[TBL] [Abstract][Full Text] [Related]
9. Lipid-lowering and antiatherosclerotic effect of NK-104, a potent 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in Watanabe heritable hyperlipidemic rabbits.
Suzuki H; Yamazaki H; Aoki T; Kojima J; Tamaki T; Sato F; Kitahara M; Saito Y
Arzneimittelforschung; 2000 Nov; 50(11):995-1003. PubMed ID: 11187394
[TBL] [Abstract][Full Text] [Related]
10. Preventive effect of pravastatin sodium, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis and xanthoma in WHHL rabbits.
Watanabe Y; Ito T; Shiomi M; Tsujita Y; Kuroda M; Arai M; Fukami M; Tamura A
Biochim Biophys Acta; 1988 Jun; 960(3):294-302. PubMed ID: 3132979
[TBL] [Abstract][Full Text] [Related]
11. Pravastatin inhibits expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in Watanabe heritable hyperlipidemic rabbits: a new pleiotropic effect of statins.
Hofnagel O; Luechtenborg B; Eschert H; Weissen-Plenz G; Severs NJ; Robenek H
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):604-10. PubMed ID: 16373606
[TBL] [Abstract][Full Text] [Related]
12. Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits.
Fukumoto Y; Libby P; Rabkin E; Hill CC; Enomoto M; Hirouchi Y; Shiomi M; Aikawa M
Circulation; 2001 Feb; 103(7):993-9. PubMed ID: 11181475
[TBL] [Abstract][Full Text] [Related]
13. Suppression of established atherosclerosis and xanthomas in mature WHHL rabbits by keeping their serum cholesterol levels extremely low. Effect of pravastatin sodium in combination with cholestyramine.
Shiomi M; Ito T; Watanabe Y; Tsujita Y; Kuroda M; Arai M; Fukami M; Fukushige J; Tamura A
Atherosclerosis; 1990 Jul; 83(1):69-80. PubMed ID: 2117930
[TBL] [Abstract][Full Text] [Related]
14. Natural history of atherosclerosis and hyperlipidemia in heterozygous WHHL (WHHL-Hh) rabbits. II. Morphologic evaluation of spontaneously occurring aortic and coronary lesions.
Esper E; Runge WJ; Gunther R; Buchwald H
J Lab Clin Med; 1993 Jan; 121(1):103-10. PubMed ID: 8426070
[TBL] [Abstract][Full Text] [Related]
15. Fluvastatin suppresses atherosclerotic progression, mediated through its inhibitory effect on endothelial dysfunction, lipid peroxidation, and macrophage deposition.
Bandoh T; Mitani H; Niihashi M; Kusumi Y; Kimura M; Ishikawa J; Totsuka T; Sakurai I; Hayashi S
J Cardiovasc Pharmacol; 2000 Jan; 35(1):136-44. PubMed ID: 10630744
[TBL] [Abstract][Full Text] [Related]
16. Pravastatin inhibits plaque rupture and subsequent thrombus formation in atherosclerotic rabbits with hyperlipidemia.
Wu G; Xie Q; Xu L; Jiang H; Huang Z; Huang C
Chem Pharm Bull (Tokyo); 2013; 61(2):121-4. PubMed ID: 23207681
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol-fed heterozygous Watanabe heritable hyperlipidemic rabbits: a new model for atherosclerosis.
Atkinson JB; Hoover RL; Berry KK; Swift LL
Atherosclerosis; 1989 Aug; 78(2-3):123-36. PubMed ID: 2783197
[TBL] [Abstract][Full Text] [Related]
18. Effects of low-dose pravastatin sodium on plasma cholesterol levels and aortic atherosclerosis of heterozygous WHHL rabbits fed a low cholesterol (0.03%) enriched diet for one year.
Harsch M; Braesen JH; Niendorf A
Atherosclerosis; 1997 Feb; 128(2):139-47. PubMed ID: 9050770
[TBL] [Abstract][Full Text] [Related]
19. Pactimibe stabilizes atherosclerotic plaque through macrophage acyl-CoA:cholesterol acyltransferase inhibition in WHHL rabbits.
Kitayama K; Koga T; Maeda N; Inaba T; Fujioka T
Eur J Pharmacol; 2006 Jun; 539(1-2):81-8. PubMed ID: 16690054
[TBL] [Abstract][Full Text] [Related]
20. Effect of combined treatment with an angiotensin II receptor antagonist and an HMG-CoA reductase inhibitor on atherosclerosis in genetically hyperlipidemic rabbits.
Kato M; Sada T; Mizuno M; Kitayama K; Inaba T; Koike H
J Cardiovasc Pharmacol; 2005 Oct; 46(4):556-62. PubMed ID: 16160612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
